Evidence map›Paper›PMID 35448723›Full record

ArticleTomography (Ann Arbor, Mich.)2022

Diagnostic Performance of Preoperative Choline-PET/CT in Patients Undergoing Salvage Lymph Node Dissection for Recurrent Prostate Cancer: A Multicenter Experience.

Łukasz Nyk, Hubert Kamecki, Wojciech Krajewski, Bartosz Małkiewicz, Tomasz Szydełko, Markiian Kubis, Marcin Słojewski, Piotr Kryst, Sławomir Poletajew, Wojciech Malewski

Open access · goldAbstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Tomography (Ann Arbor, Mich.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Łukasz NykSecond Department of Urology, Centre of Postgraduate Medical Education, 01-809 Warsaw, Poland.
Hubert KameckiSecond Department of Urology, Centre of Postgraduate Medical Education, 01-809 Warsaw, Poland.
Wojciech KrajewskiDepartment of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wrocław Medical University, 50-556 Wrocław, Poland.
Bartosz MałkiewiczDepartment of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wrocław Medical University, 50-556 Wrocław, Poland.ORCID 0000-0002-5933-3753
Tomasz SzydełkoDepartment of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wrocław Medical University, 50-556 Wrocław, Poland.
Markiian KubisDepartment of Urology and Urological Oncology, Pomeranian Medical University, 70-111 Szczecin, Poland.
Marcin SłojewskiDepartment of Urology and Urological Oncology, Pomeranian Medical University, 70-111 Szczecin, Poland.
Piotr KrystSecond Department of Urology, Centre of Postgraduate Medical Education, 01-809 Warsaw, Poland.
Sławomir PoletajewSecond Department of Urology, Centre of Postgraduate Medical Education, 01-809 Warsaw, Poland.ORCID 0000-0001-7664-9816
Wojciech MalewskiSecond Department of Urology, Centre of Postgraduate Medical Education, 01-809 Warsaw, Poland.
Postgraduate School of Molecular Medicine · PLWroclaw Medical University · PLPomeranian Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to retrospectively analyze consecutive prostate cancer patients diagnosed with biochemical or clinical recurrence after local treatment with curative intent, with no evidence of distant metastases, who underwent positron emission tomography/computed tomography (PET/CT) with choline followed by salvage lymph node dissection (SLND) in three academic centers between 2013 and 2020. A total of 27 men were included in the analyses. Sensitivity, specificity, positive and negative predictive values, and accuracy of choline-PET/CT in predicting pathology-proven lymph node involvement were 75%, 43%, 79%, 38% and 67% on per-patient and 70%, 86%, 80%, 78%, and 79% on per-site analyses, respectively, with the differences in specificity and NPV between per-patient and per-site analyses being statistically significant (

Indexed as

Positron Emission Tomography Computed TomographyProstatic NeoplasmsCholineHumansLymph Node ExcisionMaleNeoplasm Recurrence, LocalRetrospective StudiesCholinepositron emission tomography computed tomographypredictive value of testsprostatic neoplasmssalvage therapysensitivity and specificity

Identifiers

PMID35448723
PMCPMC9031841
OpenAlexW4223903860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.